Navigating TKI Selection in HER2-Mutant NSCLC | OncLive
Navigating TKI Selection in HER2-Mutant NSCLC | OncLive
1 month ago
onclive.com
The Role of Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC Management | OncLive
The Role of Amivantamab Plus Lazertinib in EGFR-Mutated NSCL…
2 months ago
onclive.com
Evaluating Zongertinib After ADC Therapy: Efficacy, Safety, and ILD Considerations in HER2 Mutant NSCLC | OncLive
Evaluating Zongertinib After ADC Therapy: Efficacy, Safety, and ILD …
4 months ago
onclive.com
Sunvozertinib for NSCLC With EGFR Exon 20
Sunvozertinib for NSCLC With EGFR Exon 20
2 months ago
vumedi.com
FDA Approval of Sunvozertinib for Locally Advanced or Metastatic NSCLC Harboring EGFR exon 20 Insertion Mutations
FDA Approval of Sunvozertinib for Locally Advanced or Metastatic N…
9 months ago
vumedi.com
Dr. Camidge on Toxicities of Sunvozertinib in EGFR Exon 20–Mutated NSCLC | OncLive
Dr. Camidge on Toxicities of Sunvozertinib in EGFR Exon 20–M…
Oct 20, 2022
onclive.com
Dr. Planchard on the Benefit of Sunvozertinib in EGFR Exon 20–Mutated NSCLC | OncLive
Dr. Planchard on the Benefit of Sunvozertinib in EGFR Exon 20–M…
Sep 2, 2022
onclive.com
1:37
Zongertinib 71% ORR for HER2-Mutant NSCLC: Key Insights from …
May 2, 2025
oncologytube.com
Overview of Targeted Therapy Updates in NSCLC (Zongertinib, T…
7 months ago
vumedi.com
NSCLC: EGFR Exon 20 Insertion Treatment Options | OncLive
Jul 22, 2021
onclive.com
Combination Therapy: A New Frontline Standard in the Treatme…
Apr 28, 2025
onclive.com
NSCLC & Targeted Therapy: A Brief Overview and Update in the Metas…
1.2K viewsDec 13, 2023
vumedi.com
EGFR Exon 20 Insertion Mutations in NSCLC: Optimal and “Soon to B…
210 viewsDec 4, 2023
vumedi.com
4:17
Dr Nicolas Girard on LUMINOSITY: Teliso-V Improves PROs in NSCL…
Sep 16, 2024
ajmc.com
Dr Zhang on Sacituzumab Tirumotecan in Pretreated Advanc…
10 months ago
onclive.com
Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvoze…
10 months ago
marketscreener.com
KEYNOTE-091 Evaluates Adjuvant Pembrolizumab in Resected Early …
Jul 19, 2022
targetedonc.com
Clinical Insights on Osimertinib in Frontline Therapy for EGFR-Mutat…
Oct 16, 2024
onclive.com
Insights from COCOON: Prophylactic Dermatologic Manag…
Apr 15, 2025
targetedonc.com
Data From FLAURA2: Osimertinib With or Without Chemotherapy in …
Sep 21, 2023
targetedonc.com
1:14
Predictive Biomarkers for Treatment With Amivantamab Plus Lazertini…
Apr 29, 2024
onclive.com
2:17
Dr Heymach on the Efficacy of Zongertinib in Previously Treated …
Apr 29, 2025
onclive.com
8:14
Osimertinib After Definitive Chemoradiotherapy in Patients wit…
Apr 16, 2025
onclive.com
1:22
Oncolytic Virotherapies in Ovarian Cancer, NSCLC
13 views1 month ago
YouTubeXtalks
Emerging Treatment Options in 2L Treatment of mNSCLC With HER2 …
7 months ago
onclive.com
The Treatment Landscape For Advanced EGFR-Mutant NSCLC | …
10 months ago
oncnursingnews.com
42:48
Immunotherapy for Lung Cancer
14.7K viewsJan 18, 2016
YouTubeGlobal Resource for Advancing Cancer Education
2:21
Osimertinib in Advanced Non–Small-Cell Lung Cancer
47.4K viewsFeb 16, 2017
YouTubeNEJM Group
3:30
Immunotherapy Treatments for Non-Small Cell Lung Cancer (NSCLC)
83.7K viewsAug 6, 2020
YouTubeYou and Lung Cancer
5:48
Oncogene-addicted NSCLC
2.4K views7 months ago
YouTubeCOR2ED The Heart of Medical Education
See more videos
Static thumbnail place holder